Zobrazeno 1 - 10 of 88 pro vyhledávání: '"Arthur F. Kavanaugh"'
1
Periodical
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic diseasemodifying antirheumatic drugs in rheumatoid arthritisMembers of the Core Expert Panel: Kenneth G. Saag, MD, MSc, Jeffrey R. Curtis, MD, MPH, Harold E. Paulus, MD, Jeroan J. Allison, MD, MS, Maria Suarez Almazor, MD, MPH, S. Louis Bridges, Jr., MD, PhD, W. Winn Chatham, MD, Marc Hochberg, MD, MPH, Catherine MacLean, MD, PhD, Ted Mikuls, MD, MSPH, Larry W. Moreland, MD, James ODell, MD, Anthony M. Turkiewicz, MD, Daniel E. Furst, MD.Members of the Task Force Panel: Claire Bombardier, MD, MSc University of Toronto, Toronto, Ontario, Canada, Robin K. Dore, MD University of California, Los Angeles, Linda F. Golodner, BA National Consumers League, Washington, DC, Sean Hennessy, PharmD, PhD University of Pennsylvania School of Medicine, Philadelphia, Arthur F. Kavanaugh, MD University of California, San Diego, Dinesh Khanna, MD, MSC University of Cincinnati, Cincinnati, Ohio, current address:
Autor: Saag, Kenneth G., Teng, Gim Gee, Patkar, Nivedita M., Anuntiyo, Jeremy, Finney, Catherine, Curtis, Jeffrey R., Paulus, Harold E., Mudano, Amy, Pisu, Maria, ElkinsMelton, Mary, Outman, Ryan, Allison, Jeroan J., Almazor, Maria Suarez, Bridges, S. Louis, Chatham, W. Winn, Hochberg, Marc, Maclean, Catherine, Mikuls, Ted, Moreland, Larry W., Odell, James, Turkiewicz, Anthony M., Furst, Daniel E.
Publikováno v: Arthritis Care and Research; June 2008, Vol. 59 Issue: 6 p762-784, 23p
Zobrazit plný text záznamu
2
Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III study
Autor: Désirée, van der Heijde, Jürgen, Braun, Martin, Rudwaleit, Oana, Purcaru, Arthur F, Kavanaugh
Publikováno v: RMD Open
Objectives To evaluate the effect of certolizumab pegol (CZP) on work and household productivity, and on participation in family, social and leisure activities in patients with axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fbfa2b32b75b37bce39c30d6058708a3
https://pubmed.ncbi.nlm.nih.gov/29670761
Zobrazit plný text záznamu
5
Risk factors for early work disability in systemic lupus erythematosus. Results from a Multicenter Study
Autor: Karin V. Straaton, Lawren H. Daltroy, Elizabeth W. Karlson, Robert A. Lew, W N Roberts, Matthew H. Liang, Arthur F. Kavanaugh, Anne H. Fossel, S H Stern, Alison J. Partridge, Elizabeth A. Wright
Publikováno v: Arthritis & Rheumatism. 40:2199-2206
Objective. To study the risk factors for early work disability in systemic lupus erythematosus (SLE). Methods. A sample of 159 SLE patients who had been employed at some time since diagnosis was drawn from a multicenter study of outcome in SLE. Disea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d9fe480c7b1c5b7be99780e9204464e
https://doi.org/10.1002/art.1780401214
Zobrazit plný text záznamu
6
Repeat treatment of Rheumatoid Arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody
Autor: Peter E. Lipsky, Arthur F. Kavanaugh, Laurie S. Davis, Hendrik Schulze-Koops
Publikováno v: Arthritis & Rheumatism. 40:849-853
Objective. To assess the safety and efficacy of a second course of treatment with a murine monoclonal antibody (MAb) to intercellular adhesion molecule 1 (ICAM-1; CD54) in active rheumatoid arthritis (RA). Methods. In an open-label study, 8 patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a93dd185cd8516dc03de05c8ab0e294
https://doi.org/10.1002/art.1780400511
Zobrazit plný text záznamu
7
Antiadhesion Therapy in Rheumatoid Arthritis
Autor: Arthur F. Kavanaugh
Publikováno v: BioDrugs. 7:119-133
A novel therapeutic approach for systemic inflammatory diseases such as rheumatoid arthritis is directed towards adhesion receptors. Interactions mediated by adhesion receptors govern the recruitment of inflammatory cells into inflammatory sites, suc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::614df5b6ab6575b0329466521b5b0f52
https://doi.org/10.2165/00063030-199707020-00005
Zobrazit plný text záznamu
8
The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus
Autor: Robert A. Lew, W N Roberts, J M Grosflam, Lawren H. Daltroy, Alison J. Partridge, Karin V. Straaton, Anne H. Fossel, S H Stern, Matthew H. Liang, Mary C. Wacholtz, Elizabeth W. Karlson, Arthur F. Kavanaugh, Elizabeth A. Wright
Publikováno v: Arthritis & Rheumatism. 40:47-56
Objective. To study the relationship of race, socioeconomic status (SES), clinical factors, and psychosocial factors to outcomes in patients with systemic lupus erythematosus (SLE). Methods. A retrospective cohort was assembled, comprising 200 patien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e59bc6395e1a29129831d5ae2a50f6f
https://doi.org/10.1002/art.1780400108
Zobrazit plný text záznamu
9
Cost evaluation of novel therapeutics in rheumatoid arthritis (CENTRA):A decision analysis model
Autor: Arthur F. Kavanaugh, Gustavo R. Heudebert, John J. Cush, Rita Jain
Publikováno v: Seminars in Arthritis and Rheumatism. 25:297-307
This study was performed to evaluate the potential costs of a hypotheticalnovel biological agent (BIO) as a therapy for rheumatoid arthritis (RA), compared with oral methotrexate (MTX) and intramuscular gold (IMG). A decision analysis model was used
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe690c201cf02f88e453768560976043
https://doi.org/10.1016/s0049-0172(96)80016-3
Zobrazit plný text záznamu
10
BIOLOGIC INTERVENTIONS IN RHEUMATOID ARTHRITIS
Autor: Arthur F. Kavanaugh, John J. Cush
Publikováno v: Rheumatic Disease Clinics of North America. 21:797-816
An increasing understanding of the immunopathogenesis of rheumatoid arthritis and advances in biotechnology have lead to the therapeutic application of immune-specific interventions. The complexity of this disorder has generated numerous investigatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::de16e1fcef95ad59236060ced583cdeb
https://doi.org/10.1016/s0889-857x(21)00468-3
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje